What is Manhattan Endoscopy?
Manhattan Endoscopy Center operates as a premier outpatient surgical facility, strategically located in New York to serve a diverse patient demographic. The center specializes in complex gastroenterology and hepatology, providing a comprehensive suite of diagnostic and therapeutic gastrointestinal endoscopy procedures. With a core focus on colorectal cancer prevention and advanced hemorrhoid treatment, the facility integrates high-quality specialty care with a patient-centered approach. By maintaining accessibility through the acceptance of major insurance plans, including Medicare and Medicaid, the center has solidified its reputation as a vital component of the regional healthcare infrastructure, supported by a team of highly experienced gastroenterologists.
How much funding has Manhattan Endoscopy raised?
Manhattan Endoscopy has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Manhattan Endoscopy
PPP
Public-Private Partnership
What's next for Manhattan Endoscopy?
With the recent influx of capital, Manhattan Endoscopy is poised to scale its clinical operations and potentially expand its diagnostic capabilities. The late-stage nature of this funding suggests a focus on optimizing patient throughput and investing in cutting-edge medical technology to maintain its competitive edge in the gastroenterology sector. Future strategic initiatives will likely prioritize the integration of advanced procedural workflows and the expansion of its specialized care team to meet the growing demand for outpatient gastrointestinal services in the metropolitan area. This financial backing provides the necessary runway to solidify its market dominance and improve long-term clinical outcomes for its patient base.
See full Manhattan Endoscopy company page
